Skip to main content

Table 3 Association between CLU expression and clinicopathological factors in early-stage ovarian cancer

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Factor

CLU expression

P-value

 

Low

high

 

Age

  

0.83

<50

16

8

 

> = 50

16

7

 

Histology

  

0.32

Serous/endometrioid

11

3

 

Mucinous/clear cell

21

12

 

Stage

  

0.09

Ia/b

13

2

 

Ic/II

19

13